Participant characteristic . | CDAH study sample . | Australian general population . |
---|---|---|
Current smokers* | ||
Men | 23 | 34 |
Women | 20 | 26 |
Professional/managers | ||
Men | 51.7 | 40 |
Women | 48.3 | 35 |
Overweight and obese† | ||
Men | 62 | 58 |
Women | 38 | 35 |
Antidepressant use | 4 | 3.6 |
Depression‡ | ||
Men | 5.4 | 5.8 |
Women | 11.7 | 10.1 |
Participant characteristic . | CDAH study sample . | Australian general population . |
---|---|---|
Current smokers* | ||
Men | 23 | 34 |
Women | 20 | 26 |
Professional/managers | ||
Men | 51.7 | 40 |
Women | 48.3 | 35 |
Overweight and obese† | ||
Men | 62 | 58 |
Women | 38 | 35 |
Antidepressant use | 4 | 3.6 |
Depression‡ | ||
Men | 5.4 | 5.8 |
Women | 11.7 | 10.1 |
Data are %.
*Current smokers include those who smoke daily or weekly.
†Overweight and obese includes individuals with a BMI ≥25 kg/m2.
‡Depression assessment for the Australian general population was undertaken using the mood module of the Primary Care Evaluation of Mental Disorders (PRIME-MD) instrument. Scoring to determine depression “caseness” used the PRIME-MD method for detection of DSM-IV diagnoses.